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Objective: The purpose of this study was to determine relationships between lower-extremity arterial obstruction, leg
strength, and lower-extremity functioning.
Design: The study design was cross-sectional. A total of 514 outpatients (269 with ankle-brachial index [ABI] <0.90),
aged 55 and older, were identified from three Chicago-area hospitals. Individuals with history of lower-extremity
revascularization were excluded.
Main outcome measures: Strength in each leg, 6-minute walk, 4-meter walking velocity, accelerometer-measured physical
activity, and a summary performance score were measured. The summary performance score is a composite measure of
lower-extremity functioning, ranging from 0 to 12 (12  best). The leg with the lower ABI was defined as the “index”
leg, and the leg with higher ABI was defined as the “contralateral” leg.
Results: Index leg ABI levels were associated linearly and significantly with strength for hip extension (P < .001), hip
flexion (P < .001), knee extension (P  .066), and knee flexion (P  .003), adjusting for known and potential
confounders. In adjusted analyses, the index ABI was also associated linearly and significantly with strength in the
contralateral leg. Adjusting for confounders, including ABI, knee extension strength, was associated independently with
functional measures.
Conclusion: Among patients without prior leg revascularization, strength in each leg is highly correlated with the
lower-leg ABI. Leg strength is associated independently with functional performance. Further study is needed to
determine whether lower-extremity resistance training improves functioning in patients with peripheral arterial disease.
(J Vasc Surg 2004;39:523-30.)
Loss of lower-extremity muscle mass and strength are
increasingly recognized as causes of disability in patients
with chronic disease.1-6 In older, frail individuals, resistance
training of the legs improves functioning, increases aerobic
capacity, and increases treadmill-walking distance.7-9 Re-
duced leg strength associated with arterial obstruction can
be one mechanism by which lower-extremity peripheral
arterial disease (PAD) impairs functioning. Men and
women with PAD have atrophy and reduced numbers of
lower-extremity skeletal muscle fibers as compared with
patients without PAD.10,11 However, to our knowledge
only two prior studies have assessed the relation between
PAD and leg strength.11,12 Results of those two studies
were conflicting: one study showed impaired strength in
persons with PAD, and the second study did not show a
reduction in leg strength among persons with PAD.
We assessed relations between lower-extremity arterial
obstruction and leg strength in a large sample of men and
women with and without PAD. We determined whether
lower ankle-brachial index (ABI) levels are associated with
greater impairments in leg strength. To determine whether
lower-extremity arterial obstruction directly impairs skele-
tal muscle strength, we compared relations between the
lower-leg ABI and both ipsilateral and contralateral leg
strength. We reasoned that if lower-extremity arterial ob-
struction impairs strength, then the lower ABI may be
highly correlated with strength in the ipsilateral but not the
contralateral leg. Alternatively, because of disuse atrophy,
leg strength could be similarly reduced in the index and
contralateral legs. Finally, we assessed relations between leg
strength and functioning among men and women with
PAD, to determine whether leg strength mediates the
relation between ABI and functioning in PAD.
METHODS
Participation identification
The protocol was approved by Institutional Review
Boards at Northwestern University’s Feinberg School of
Medicine and Catholic Health Partners Hospitals. Partici-
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pants were aged 55 or older, and all gave informed consent.
Of those participants with PAD, most were identified from
three Chicago-area noninvasive vascular laboratories. A
small number were identified from among consecutively
identified patients in a large general internal medicine
(GIM) practice who were screened with the ABI. Half of
the participants without PAD were identified from among
consecutive patients with normal lower-extremity arterial
tests in the three Chicago-area noninvasive vascular labora-
tories, and half were identified from among consecutive
patients with appointments in the GIM practice.
Exclusion criteria
PAD was defined as ABI 0.90. Absence of PAD was
defined as ABI 0.90 to 1.50.13,14 Patients with ABI values
greater than 1.50 were excluded because ABI 1.50 indi-
cates poorly compressible leg arteries and inability to gauge
arterial obstruction accurately. Patients diagnosed with
PAD in the vascular laboratories were excluded if they had
a normal ABI at their study visit. Similarly, patients with a
normal ABI from the vascular laboratories were excluded if
they had ABI0.90 at the study visit. The total number of
participants excluded because of one of these ABI criteria
was 151.
Patients with dementia were excluded because of con-
cern about their ability to answer questions accurately (n
7). Those patients with severely impaired functioning were
also excluded. These exclusions included nursing home
residents (n  65), wheelchair-bound patients (n  33),
and patients with foot or leg amputations (n  80). Non–
English-speaking patients were excluded because the re-
search staff members were not fluent in non-English lan-
guages (n  61). Because we did not have information on
graft patency, selection criteria, or postsurgical manage-
ment of PAD, individuals with history of lower-extremity
revascularization were excluded from analyses (n  168).
Ankle-brachial index measurement
The ABI was measured by using previously established
methods.13,14 Lower-extremity blood pressure cuffs were
placed at the ankles, 3 cm above the malleoli. Participants
rested supine for 5 minutes prior to the ABI. Systolic
pressures were measured in the right brachial artery, right
dorsalis pedis and posterior tibial arteries, left dorsalis pedis
and posterior tibial arteries, and left brachial artery by using
a hand-held Doppler probe (Nicolet Vascular Pocket Dop
II, Golden, Colo). Each pressure was measured twice: first
in the order listed and then in reverse order. The ABI was
calculated in each leg by dividing the average pressures in
each leg by the average of the four brachial pressures. When
one brachial artery pressure was higher than the opposite
brachial artery pressure in both measurement sets, and the
right and left brachial artery pressures differed by 10 mmHg or
more in at least one measurement set, subclavian stenosis was
suspected. The average brachial artery pressure in the arm with
higher pressure was used to calculate the ABI.14 Among
participants with and without PAD, the lower-leg ABI was
referred to as the “index” leg. The leg with higher ABI was
referred to as the “contralateral” leg. For individuals with
identical ABI values in the left and right legs, the right leg was
designated as the index leg a priori. Unless otherwise indi-
cated, the index leg ABI was used in analyses.
Leg symptom groups
Using the San Diego claudication questionnaire, we
characterized leg symptoms into one of five mutually ex-
clusive leg symptom groups. The five groups have been
described previously15 and consisted of the following: (1)
intermittent claudication, (2) atypical exertional leg pain/
stop, (3) atypical exertional leg pain/carry on, (4) leg pain
on exertion and rest, and (5) no exertional leg pain.
Comorbidities
We documented comorbidities by using methods from
the Women’s Health and Aging Study and the Cardiovas-
cular Health Study.16-18 Disease-specific algorithms com-
bined data from patient report, physical examination, med-
ical record review, medications, laboratory values, and
primary care physician questionnaire. Criteria developed by
the American College of Rheumatology were used to diag-
nose knee and hip osteoarthritis.19,20 Comorbidities as-
sessed were angina pectoris, diabetes mellitus, myocardial
infarction, stroke, heart failure, pulmonary disease, knee
and hip arthritis, spinal stenosis, disk disease, and hip frac-
ture. These comorbidities were chosen because they are
associated with impaired functioning.17,18 Angina pectoris,
myocardial infarction, stroke, and heart failure were com-
bined into one category of cardiac or cerebrovascular dis-
ease. Hip or knee arthritis, spinal stenosis, disk disease, and
hip fracture were combined into one category of arthritis. A
category of “other comorbid disease” was defined to in-
clude cancer and pulmonary disease.
Neuropathy
We used a monofilament to assess sensation in 11
locations on the dorsal and ventral surface of each foot,
based on previous study.21,22 Potential scores ranged from
0 to 22, where 0 indicated that the participant detected all
locations tested with the monofilament and 22 indicated
that none of the locations were detected.
Lower-extremity functional measures
Six-minute walk. Following a standardized protocol,
participants walked up and down a 100-foot hallway for 6
minutes, covering as much distance as possible. The
6-minute walk test is highly reliable in patients with PAD
(reliability coefficient  0.94).23
Accelerometer-measured physical activity. The Cal-
trac vertical accelerometer was used to measure physical
activity levels over 7 days. This device is worn at the waist.
To compare activity levels between participants regardless
of individual variation in age, weight, height, and sex, we
programmed accelerometers with identical values for those
four characteristics by using previously reported meth-
ods.24 Thus, the accelerometers measured “activity units.”
Participants were telephoned at the end of the 7-day period
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to obtain the final number of activity units displayed on the
accelerometer. Because of a shortage of accelerometers,
they were distributed only to 49% of the participants. There
were no significant differences in age, race, sex, or average
ABI of participants between those participants who did or
did not wear the accelerometer.
Summary performance score
Repeated chair rises. The repeated chair rise test mea-
sures leg strength and balance.25-27 Participants sit in a
straight-backed chair with arms folded across their chest
and stand up five consecutive times as quickly as possible.
Time required for the five chair rises was measured.
Fig 1. Reasons for nonparticipation among potentially eligible identified patients. PAD, Peripheral artery disease.
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Standing balance. Participants attempt to hold three
increasingly difficult standing positions for 10 seconds
each: standing with feet together side by side, standing with
the toes of one foot adjacent to the heel of the second foot
while feet were parallel, and standing with one foot directly
in front of and in contact with the other.25-27
Four-meter walking velocity. The walking velocity
of each participant was measured over a marked 4-meter
distance in a hallway.25-27 Participants walked this distance
twice at their “usual” pace. The faster walk was used in
analyses.
Calculating the summary performance score. The
summary performance score predicts risk of future nursing
home placement, mobility loss, and mortality among com-
munity-dwelling older men and women.25-27 The score is
calculated by assigning a value of 0 to 4 for performance on
4-meter walking velocity, five chair rises, and standing
balance, respectively, based on cut points derived from
normative data of representative community populations.
The sum of these three scores is the summary performance
score, ranging from 0 to 12 (12  best).27
Leg strength
Leg strength for each participant was measured by
using a musculoskeletal fitness evaluation (MFE) chair. The
MFE chair measures isometric strength in Newton-meters
for knee flexion, knee extension, hip flexion, and hip exten-
sion by using strain gauges connected to a computerized
data-collecting unit. Participants sat in the MFE chair and
pushed against leg attachments for 5 seconds. They were
instructed to build to their maximum strength. The highest
recorded strength during the last 3 seconds of effort was
used in analyses. Strength measurements were performed
twice, and the higher value was used in analyses.
Body mass index
Height and weight were measured at the study visit.
Body mass index (BMI) was calculated as kg/m2.
Statistical analyses
Differences in characteristics of the study population
were assessed by using age- and sex-adjusted general linear
models for continuous variables and binary variables. For
binary variables, the test of significance was based on logis-
tic regression models.
Among persons with and without PAD, mean strength
in the index and contralateral legs were compared across
the index leg ABI categories (ABI 0.50, ABI 0.50-
0.70, ABI 0.70-0.90, ABI 0.90-1.10, and ABI 1.10-
1.50) by using general linear models. The test for linear
trend across the ABI categories was based on multiple linear
regression analyses, using ABI as an independent variable.
These analyses were repeated, adjusting for known and
potential confounders: age, sex, race (African American
versus non–African American), education, BMI, comorbid
diseases, neuropathy score, and leg symptoms.
To account for the interdependence of the leg data on
the same patient, the relations between ABI and strength in
the index and contralateral legs among PAD participants
whose ABI differed by at least 0.20 were compared by using
linear mixed models, adjusting for age, sex, and race. These
analyses were repeated among participants with ABI 1.10-
1.50 in both legs.
The independent relation between ABI and each func-
tional measure was determined by using multiple linear
regression analyses, adjusting for age, sex, race, education,
BMI, number of comorbid diseases, neuropathy score, and
leg symptoms. These analyses were repeated with the addi-
tional adjustment for the four leg strength variables in the
index leg, to determine whether associations between ABI
and functioning were attenuated after additional adjust-
ment for leg strength. All analyses were performed by using
SAS statistical software version 8.2 (SAS Institute Inc,
Cary, NC). P values were two-tailed, and P  .05 was
considered to indicate statistical significance, except as
noted earlier.
Table I. Age and sex-adjusted characteristics of





African American race, % 17 16
Ankle-brachial index* 0.662 1.09
Currently smoke, %* 18 5
Comorbidities
Arthritis, %* 41 58
Diabetes, %† 30 19
Cardiac or cerebrovascular disease, %* 55 40
Lower extremity functional measures
Six-minute walk distance, ft* 1173 1402
Four-meter normal pace velocity,
m/sec‡
0.891 0.930






Summary performance score, 0-12
score (12  best)
9.57 9.93
Strength in index leg, Newton-meters
Hip extension* 61.4 71.6
Hip flexion* 54.0 61.7
Knee extension 46.3 49.5
Knee flexion* 29.1 35.4
Strength in contralateral leg, Newton-
meters
Hip extension* 60.7 74.6
Hip flexion* 54.6 62.9
Knee extension§ 47.1 51.4
Knee flexion* 29.4 36.4
Values are expressed as means (SD) and adjusted means unless otherwise
indicated. Cardiac or cerebrovascular disease is defined as one or more of the
following: history of myocardial infarction, heart failure, angina, stroke.
Arthritis is defined as one or more of the following: spinal disc disease, hip
and knee arthritis, hip fracture, and spinal stenosis. Index leg refers to leg
with lower ABI. Contralateral leg refers to leg with higher ABI.
P values for comparisons between the PAD and non-PAD groups: *P 
.001, †P  .003, ‡P  .03, §P  .01.
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RESULTS
Fig 1 shows the number of study participants among
those identified.
The average age of participants with PAD was 73.2
years 8.0 versus 69.5 years 8.1 for participants without
PAD (P  .001). Among individuals with PAD, 56.9%
were men versus 48.6% among those without PAD. Among
participants with ABI 0.90, we found that 30.5% had
intermittent claudication and 19.7% had no exertional leg
pain. Table I shows characteristics of the study population.
Leg strength was higher in participants without PAD than
in participants with PAD.
Fig 2 and Fig 3 show relations between ABI and leg
strength. In unadjusted and fully adjusted analyses, we
observed significant linear relations between ABI and
strength in the index leg and between ABI and strength in
the contralateral leg. For each ABI category, average
strengths were similar between the index and contralateral
legs (Fig 2-3). Leg strength in patients with ABI 0.90 to
1.10 was consistently lower than strength in patients with
ABI 1.10 to 1.50.
Table II shows relations between ABI and strength in
the index and contralateral legs among PAD participants
whose ABI differed by at least 0.20 between their index and
contralateral legs. After adjusting for age, sex, and race,
there were no significant differences in strength between
the index and contralateral legs (Table II).
Table III shows regression coefficients relating ABI to
each functional measure before and after adjusting for leg
strength. Prior to adjusting for leg strength, ABI was
related significantly to each functional measure, adjusting
for known and potential confounders. These relations be-
tween ABI and functioning were attenuated slightly after
additional adjustment for strength as demonstrated by
relatively small reductions in the regression coefficients and
increases in the P value for ABI after adding the leg strength
variables to the model. Thus, leg strength appears to be a
modest contributor to the relation between ABI and leg
Fig 2. Association between lowest leg ankle-brachial index and strength in ipsilateral and contralateral legs among men
and women without prior lower-extremity revascularization (n  514).
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functioning. However, knee extension was associated sig-
nificantly with each functional measure after adjusting for
ABI and other known and potential confounders.
DISCUSSION
Among persons with and without PAD who have not
had prior lower-extremity revascularization, strength in
both legs is highly associated with the lower-leg ABI. Even
among patients with PAD with substantial differences in
ABI between their left and right legs, strength in each leg
was highly associated with the lower-leg ABI. There are
two potential explanations for this finding. First, a high
correlation between left- and right-leg ABI values may
explain why the lower-leg ABI is strongly associated with
leg strength in both legs. However, we found that the
lower-leg ABI was highly correlated with bilateral leg
strength even in patients with a difference in ABI of0.20
between the right and left legs. Alternatively, lower-ex-
tremity arterial obstruction may not directly influence leg
strength. Instead, PAD-related disuse atrophy may result in
reduced strength in both legs. Consistent with this hypoth-
esis, previous data show that the lower-leg ABI is highly
correlated with physical activity levels in patients with and
without PAD.13,24
Data reported here also show that knee extension
strength is associated with each functional outcome mea-
sure and that leg strength appears to contribute to the
associations between ABI and leg functioning. Although
our data were cross-sectional, findings are consistent with
previous study showing that progressive resistance training
in patients with PAD with intermittent claudication signif-
icantly increases treadmill walking performance, although
to a lesser degree than treadmill training.29 Thus, leg
strengthening programs may play a role in improving func-
tioning in persons with PAD. In addition, further study is
needed to determine whether increasing physical activity
levels in persons with PAD delay or prevent disuse atrophy
in lower-extremity skeletal muscles.
Our findings show that participants with low normal
ABI values of 0.90 to 1.10 have poorer leg strength than
participants with ABI values of 1.10 to 1.50. Individuals
with ABI values of 0.90 to 1.10 are likely to have mild or
subclinical PAD which may negatively affect leg
strength. Findings reported here are consistent with a
previous study showing that lower-extremity function-
ing is poorer in persons with ABI values of 0.90 to 1.10
as compared with persons with ABI values of 1.10 to
1.50.13 Finally, we found that knee extension strength
was associated independently with lower-extremity func-
tioning and physical activity level, adjusting for con-
founders, including ABI. This finding is consistent with
previous study.28
Fig 3. Adjusted associations between lowest leg ankle-brachial index and strength in ipsilateral and contralateral legs
among men and women without prior lower-extremity revascularization (n  514).
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Previous studies have shown inconsistent results re-
garding PAD and leg strength. Regensteiner et al11 studied
26 men with PAD and intermittent claudication and 6
age-matched control subjects without PAD. Gastrocne-
mius muscle strength in the leg with lower ABI among
participants with PAD was 43% less than control subjects,
and anterior tibial muscle strength was 31% less than that of
control subjects. However, another study found no reduc-
tion in hip and knee extensor muscle strength in 31 patients
with PAD and intermittent claudication as compared with
15 control subjects without PAD.12 In contrast to these
studies, our population included more participants and
included participants with PAD with and without intermit-
tent claudication.
Our study is limited by its cross-sectional design. Our
data do not allow us to determine whether reduced leg
strength in patients with PAD is a direct effect of lower-
extremity ischemia, whether it is secondary to PAD-related
inactivity and muscle atrophy, or whether it is due to an
unidentified confounder. However, to our knowledge, no
prior studies have described the relation between leg
strength and ABI level in a large cohort of patients with and
without PAD. Participants in this study were identified
from noninvasive vascular laboratories and a large general
medicine practice. Findings may not be generalizable to
individuals in other settings. However, our recruitment
methods allowed us to identify participants with a wide
range of PAD severity who are regularly encountered by
practicing clinicians.
In frail, older patients with heart failure and chronic
obstructive pulmonary disease, resistance training of the
legs improves functioning, increases aerobic capacity, and
increases treadmill-walking time.7-9 Our data suggest that
further study is justified to determine whether lower-extrem-
ity resistance training improves performance on measures of
lower-extremity functioning in patients with PAD. Pro-
spective study is also needed to determine the effects of
lower-extremity revascularization on leg strength.
Table II. Adjusted comparisons in leg strength between the index (lower ABI) and contralateral legs in patients whose
right- and left-leg ankle-brachial index differ by 0.20















P  .107 58.4
58.2
P  .955 55.9
60.3









P  .587 54.6
56.2
P  .411 52.6
51.5









P  .220 44.4
46.5
P  .323 44.3
48.3









P  .700 30.1
30.3
P  .866 27.1
28.4
P  .487 38.7
40.0
P  .201
Analyses excluded patients with ABI level 0.90 to 1.10 and patients with prior lower-extremity revascularization. Comparisons were adjusted for age, sex, and
race. P values were derived from linear mixed models.
*Participants with ABI 1.10-1.50 in both legs.
Table III. Relationships between ankle-brachial index, leg strength, and functional performance (N  514)
Dependent variables

















Six-minute walk distance, ft 507* 0.464 428* 0.526 1.05 3.78* 0.853 0.518
Four-meter normal pace
velocity, m/sec
0.099† 0.374 0.079‡ 0.0004 0.0005 0.002* 0.0002 0.406
Seven-day physical activity
(N  231)
338‡ 0.296 188 0.438 3.49 5.35† 1.76 0.339
Summary performance score,
0-12 score, (12  best)
1.43§ 0.379 1.10† 0.006 0.006 0.026* 0.002 0.436
Model 1 was adjusted for age, sex, race, BMI, education, comorbidities (cardiac or cerebrovascular disease, arthritis, pulmonary disease, cancer, diabetes),
neuropathy score, and leg symptoms. Additional adjustments were made in Model 2 for leg strength (hip extension, hip flexion, knee extension, and knee
flexion) in leg with lower ABI. Values shown are regression coefficients () unless otherwise indicated. In each model, the functional outcome was the
dependent variable. Regression coefficients represent the change in each functional outcome for each unit change in the independent variables (ankle-brachial
index, hip extension, hip flexion, knee extension, knee flexion), controlling for other variables in the model. Leg strength was measured in Newton-meters.
*P  .001; †P  .01; ‡P  .05; §P  .002.
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